About this trial
The objective of this study is to evaluate the clinical impact of the NOL nociception level index monitoring on intraoperative and post operative patient outcomes and institutional metrics when used to guide intraoperative analgesia dosing in patients undergoing spine surgery under general anesthesia when compared to a case controlled retrospective cohort.
Eligibility criteria
Qualifiers
Age > 18 years old.
ASA I-III
Elective spine surgery (laminectomy, spinal fusion, and disc replacement) under general anesthesia.
Opioid tolerant and patients with documented chronic pain may be included
Disqualifiers
• Use of any type of anesthesia other than general anesthesia (neuraxial, epidural analgesia or local regional anesthesia)
Use of intraoperative methadone
Non-sinus heart rate
Pregnancy/lactation
Trial design
Treatments tested in this trial
- NOL guided intraoperative analgesia
Treatment groups
Sponsors and collaborators
Medasense Biometrics Ltd
Lead sponsor
Thomas Jefferson Health
Collaborator